Table 1. Population of the study, summary of findings and treatment outcomes.

Patient	Breed	Gender	Age Years	HCT %	PLT K/µl	Treatment overview	Micro	Outcome
1	Pomeranian	M (N)	7	13.1	131	2AA + BT	N–	F-AA
2	Pomeranian	F (N)	8	14.2	66	1AA + BT	NP	CR-AA
3	Schnauzer	M (N)	2	20	43	2AA	P+	F-AA
4	Mongrel	M (N)	6	52	19	1AA/1MCD	P+	F-AA/CR-MCD
5	Collie	F (N)	4	28.1	55	1AA/1MCD	NP	F-AA/CR-MCD
6	Pekingese	M (N)	12	20.4	19	2AA + BT	NP	F-AA
7	G.Retriever	M (N)	10	22	16	1AA	P+	CR-AA
8	Shih Tzu	M (N)	6	40.4	6	2AA	N–	CR-AA
9	Shih Tzu	F (E)	7	32	2	2AA	N–	CR-AA
10	Akita	F (E)	8	23.8	0	1AA	P+	CR-AA
11	Labrador	F (N)	4	9	35	2AA + BT/1MCD	NP	F-AA/CR-MCD
12	Maltese	M (E)	7	15	8	4AA + BT/1MCD	N–	F-AA/CR -MCD
13	Corgi	M (N)	7	16.8	55	3AA + BT	P+	F-AA, NF-AA
14	Mongrel	F (E)	13	14.5	1	2AA + BT	P+	F-AA, NF-AA
15	Husky X	M (E)	6	16	27	2AA	N–	F-AA, NF-AA
16	Poodle	F (N)	7	32	8	2AA/1MCD	NP	F-AA/ NF-MCD
17	Schnauzer	F (N)	9	17.4	41	6AA	N–	F-AA
18	Cocker	M (E)	9	6.3	62	2AA + BT/1MCD	N–	F-AA/CR-MCD
19	G.Retriever	F (N)	3	21	10	3AA/1CDM	N–	F-AA/CR-MCD
20	Samoyed	M (E)	1	12	46	1AA /1MCD	P+	F-AA/NF-MCD
21	Poodle	M (N)	7	25.6	6	2AA/1MCD	N–	F-AA/CR-MCD
22	G.Retriever	M (N)	14	11.2	92	1AA + BT	NP	F-AA, NF-AA
23	Schnauzer	F (N)	6	19.5	824	3AA/1MCD	NP	F-AA/F-MCD
24	Maltese	M (N)	5	29.3	49	1AA	NP	CR-AA

Neutered male (M (N)), entire male (M (E)), neutered female (F (N)), entire female (F (E)), lowest haematocrit (HCT) pre-treatment, platelets (PLT) pre-treatment, atovaquone and azithromycin (AA) number of courses, blood transfusion (BT), metronidazole, clindamycin and doxycycline (MCD) number of courses, microscopic blood smear assessment (Micro), negative (N–), positive (P+), not performed (NP), failed to clear B. gibsoni after AA or MCD (F-AA, F-MCD), not followed up after AA or MCD (NF-AA, NF-MCD), clinical recovery with clearance of B. gibsoni with AA or MCD (CR-AA, CR-MCD). When two protocols where used (/) was used to separate protocols and outcomes respectively.